Smokers who switch to vaping see improvements in myocardial functions
Smokers looking to quit through vaping are often misinformed by the mountains of bogus research articles easily found through social media. If a so-called research study does not involve the same testing protocols for both smoking and vaping to determine an easy comparison, then the alleged scientific findings should be considered unreliable at best and completely fabricated at worst.
Often these falsified studies are thoroughly debunked by more reputable researchers like world-renowned cardiologist Dr. Konstantinos E. Farsalinos of the Onassis Cardiac Surgery Center in Kallithea, Greece. While many members of the anti-vaping community are currently achieving tremendous success in swaying public opinion against vaping by falsely claiming that e-cig vapor is just as lethal to the cardiovascular system as tobacco cigarette smoke, the scientific facts prove otherwise.
Study: Vaping is better for the heart than smoking
In his paper entitled Acute effects of using an electronic nicotine-delivery device (electronic cigarette) on myocardial function: comparison with the effects of regular cigarettes, Dr. Farsalinos makes perfectly clear that vaping is far better for the heart than smoking. In his study published in the medial journal BMC Cardiovascular Disorders, Dr. Farsalinos compares the myocardial effects in both vapers and smokers before making the following discoveries.
“From a public health perspective, epidemiological studies have shown that tobacco harm reduction strategy and products may be promising regarding cardiovascular disease risk reduction…Electronic cigarettes are unique since they are the only products that do not contain tobacco, while they mimic the act of smoking and provide motor and sensory stimulation. Thus, they may deal with both the chemical (nicotine delivery) and behavioural components of cigarette addiction…and studies indicate that they may be effective in promoting smoking cessation…This study provides the first clinical evidence that electronic cigarettes have less acute adverse effects on myocardial function when compared to tobacco cigarettes.”
The Farsalinos team began by selecting two groups of participants totaling 81 in number. One group consisted of daily smokers. The other was comprised of daily vapers. Dual usage was strictly forbidden, and five participants would ultimately be rejected from their respective groups before the study’s conclusion. The remaining 76 members were of an average age of 35 years. The majority were male, although four females comprised each group, as well.
Related Article: What is Joe Biden’s view on vaping?
Smokers were provided the same brand of conventional tobacco cigarettes sold in any local convenience store. Vapers were provided the same “medium strength” e-liquid with 11ml of nicotine concentration. In separate laboratories, the vapers and smokers were asked to either vape or smoke for seven minutes while the Farsalinos team monitored a variety of myocardial functions including but not limited to:
- Blood pressure
- Sitting and standing heart rates
- Cardiovascular performance index
- Left Ventricle (LV) Mass Index (MI)
- Left Ventricle (LV) Diameter
- Isovolumic relaxation time (IVRT) corrected for heart rate
- Blood Pressure (Diastolic and Systolic)
- Progressive variations in triglyceride, cholesterol, and glucose
Almost immediately upon the commencement of the seven-minute testing procedures, the researchers began witnessing some rather alarming differences in the cardiovascular measurements of the two groups. The smoking participants began experiencing immediate fluctuations on the very first puff of a cigarette while the myocardial functions of the vaping group remained relatively unchanged through the entire seven minutes.
“Baseline measurements were similar in both groups. In SM, IVRT and IVRTc were prolonged, Em and SRe were decreased, and both MPI and MPIt were elevated after smoking. In ECIG, no differences were observed after device use. Comparing after-use measurements, ECIG had higher Em (P = 0.032) and SRe (P = 0.022), and lower IVRTc (P = 0.011), MPI (P = 0.001) and MPIt (P = 0.019). The observed differences were significant even after adjusting for changes in heart rate and blood pressure.”
In the conclusionary section of the Farsalinos report, the research team readily acknowledges that more research is necessary before any conclusive results can be determined. They suggest that further studies involving larger numbers of participants might be beneficial in changing the collective mindset of U.S. government public health agencies like the Food and Drug Administration, which is currently strongly anti-vaping.
(Image courtesy of Shutterstock)